AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16425789
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg once daily for 6 weeks
Trial: 19230597
Drug: Ciprofloxacin (CFX)
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (CFX) 500 mg
Trial: 19230597
Drug: Ibuprofen (IBF)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBF) 400 mg
Trial: 16044790
Drug: Conventional evaluation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional evaluation methods (cross‐sectional studies, observational studies, comparative studies, randomised controlled trials, and metaanalyses) applied to complementary and alternative medicine
Trial: 11850711
Drug: Sequential sargramostim
RxNorm normalized name: Sargramostim
DrugBank: Sargramostim (DB00020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential sargramostim and filgrastim
Trial: 1781005
Drug: Norfloxacin (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (7 days, twice daily)
Trial: 21299925
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg methylprednisolone sodium succinate intravenously as a single bolus before surgery
Trial: 11389862
Drug: Yoghurt (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoghurt (125 g twice daily for 8 weeks)
Trial: 1977089
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg nocte
Trial: 3596336
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg nocte
Trial: 8344101
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg pem
Trial: 10204754
Drug: Nefopam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam (20 mg)
Trial: 27118212
Drug: Intramuscular paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular paracetamol (600 mg)
Trial: 27118212
Drug: Intramuscular or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular or oral syrup paracetamol (1000 mg administered six-hourly)
Trial: 27118212
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 1500 mg followed by 1000 mg maintenance dose
Trial: 27118212
Drug: Paracetamol concentrations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol concentrations
Trial: 25018116
Drug: CYD dengue
RxNorm normalized name: CYD Dengue Virus Serotype 1 Live Attenuated Antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD dengue vaccine (three injections at months 0, 6, and 12)
Trial: 25018116
Drug: CYD dengue
RxNorm normalized name: CYD Dengue Virus Serotype 1 Live Attenuated Antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD dengue vaccine
Trial: 22198447
Drug: Augmentation (N
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentation (N = 269)
Trial: 29806663
Drug: Augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentation
Trial: 20085937
Drug: Bevacizumab in
RxNorm normalized name: bevacizumab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab in combination with carboplatin and paclitaxel (PCB) with high blood pressure (HBP)
Trial: 20085937
Drug: Bevacizumab in
RxNorm normalized name: bevacizumab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab in combination with carboplatin and paclitaxel (PCB) without high blood pressure (HBP)
Trial: 12521403
Drug: Nicotine 2-mg
RxNorm normalized name: nicotine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine 2-mg sublingual tablet (n = 120)
Trial: 10604733
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg or 800 mg twice a day)
Trial: 7866815
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg twice daily for 12 weeks, followed by a maximum of four 5 mg tablets (20 mg max daily) for 12 weeks
Trial: 29101134
Drug: Steam inhalation
RxNorm normalized name: Leader Hot Steam Inhalation Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steam inhalation for recurrent sinusitis
Trial: 28439716
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic drugs
Trial: 15776065
Drug: Aromatase inhibitors
RxNorm normalized name: Aromatase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitors (specific drug not mentioned)
Trial: 15776065
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (not specified)
Trial: 11957789
Drug: Antioxidative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidative therapy
Trial: 8635777
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PN) with amino acid based glucose electrolyte solution (Vamin) and lipid emulsion (Intralipid)
Trial: 6233335
Drug: Isotretinoin 0.5
RxNorm normalized name: isotretinoin 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 0.5 mg/kg/day
Trial: 29288402
Drug: Intensive prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive prevention in kindergarten with fluoride gel at school
Trial: 29288402
Drug: Intensive prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive prevention in kindergarten without fluoride gel at school
Trial: 29288402
Drug: Basic prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic prevention in kindergarten with fluoride gel at school
Trial: 8889482
Drug: Hypotonic glucose‐electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypotonic glucose‐electrolyte solution (H)
Trial: 6297202
Drug: Glucocorticoids (dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoids (dexamethasone 2.0 mg/day for 3 days)
Trial: 6297202
Drug: Exogenous ACTH1-24
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous ACTH1-24 administration
Trial: 25730788
Drug: Cranoff (Test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranoff (Test drug)
Trial: 21087403
Drug: NGX-4010 (8%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGX-4010 (8% capsaicin dermal patch, 640 µg/cm²)
Trial: 21087403
Drug: 0.04% capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.04% capsaicin control patch (3.2 µg/cm²)
Trial: 20029098
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (5-kg medicine ball)
Trial: 11577259
Drug: Tirofiban/heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban/heparin
Trial: 21045817
Drug: Hemp Seed
RxNorm normalized name: Hemp Seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemp Seed Pill (HSP) 7.5 g b.i.d.
Trial: 19661478
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care including antidepressant
Trial: 15114207
Drug: 4 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml/kg NaCl, 7.5%
Trial: 15114207
Drug: 32 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 ml/kg NaCl, 0.9%
Trial: 30131565
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (7 mg/24 h)
Trial: 27798210
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg oral moxifloxacin
Trial: 24432626
Drug: Qilin Pills
RxNorm normalized name: Qilib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qilin Pills + levofloxacin
Trial: 18316457
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba treatment for mild-moderate dementia
Trial: 9604126
Drug: Rufinamide 600
RxNorm normalized name: Rufinamide
DrugBank: Rufinamide (DB06201)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rufinamide 600 mg after a fat and protein rich breakfast
Trial: 2513931
Drug: Needle aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle aspiration + Metronidazole 2.4 g/day for 10 days
Trial: 2513931
Drug: Metronidazole 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 2.4 g/day for 10 days
Trial: 30999260
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate (ESL) monotherapy, starting dose 1600 mg QD (or 1200 mg if previously reduced), adjustable between 800–2400 mg QD.
Trial: 28253839
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatments)
Trial: 21897336
Drug: Ethyl alcohol-intoxicated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethyl alcohol-intoxicated patients (mean ethyl alcohol, 251 [SD, 87] mg/dL)
Trial: 18452779
Drug: Fluvastatin 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 30 mg/day plus conventional calcium-channel blocker (CCB) therapy
Trial: 8466367
Drug: Cefotaxime 4
RxNorm normalized name: cefotaxime 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 4 g/day for 21 days plus aminoglycoside for 10 days
Trial: 26296296
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IPL and UVR
Trial: 15378145
Drug: Colchicine administered
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colchicine administered in 2 or 3 divided doses daily (Group I)
Trial: 9743895
Drug: Org 31710
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 31710 (75 mg)
Trial: 28831957
Drug: Walnut supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Walnut supplementation (15% energy, average 43 g/d)
Trial: 25925591
Drug: Morphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (5 mg) intravenously prior to loading dose of ticagrelor (180 mg)
Trial: 8236142
Drug: Sarulplase (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarulplase (both doses)
Trial: 31360536
Drug: Tablet computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet computer technology's audio-visual facility
Trial: 27074034
Drug: Combined H1R
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined H1R and H2R antagonist (fexofenadine and ranitidine)
Trial: 17583098
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy with grass allergen tablets (standardized tablet at different doses)
Trial: 31046016
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment of 0.01% atropine and +2.50‐diopter add center‐distance soft bifocal contact lenses (SBCL) for 2 weeks
Trial: 25962165
Drug: BG00010 (neublastin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG00010 (neublastin, artemin, enovin) 0.3, 1, 3, 10, 25, 50, 100, 200, 400, or 800 μg/kg (intravenous) or 50 μg/kg (subcutaneous)
Trial: 8069886
Drug: NaF dentifrice
RxNorm normalized name: DENTIFRICES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaF dentifrice brushed three times daily
Trial: 8069886
Drug: Fluoride-releasing device
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-releasing device (FRD; 0.07 mg F/day) plus F‐free dentifrice
Trial: 8069886
Drug: FRD (0.232
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FRD (0.232 mg F/day) plus F‐free dentifrice
Trial: 8069886
Drug: F‐free dentifrice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F‐free dentifrice three times daily
Trial: 2495079
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg combined with Warfarin
Trial: 27576370
Drug: Phlebotomy (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebotomy (6 ml/kg/2 weeks)
Trial: 27576370
Drug: Deferasirox (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferasirox (for patients with baseline serum ferritin 1,000 ng/ml or higher)
Trial: 27576370
Drug: Phlebotomy (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebotomy (for patients with baseline serum ferritin 1,000 ng/ml or higher)
Trial: 26598476
Drug: Risperidone (switched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (switched from initial medication)
Trial: 26598476
Drug: Lithium (switched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (switched from initial medication)
Trial: 15582920
Drug: Methylphenidate (16,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (16, 32 and 48 mg)
Trial: 8306751
Drug: ICI 204,219
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 204,219 (0.2 mg dose)
Trial: 3769898
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine i.m.
Trial: 31765004
Drug: Pharmacist-led education-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led education-based intervention to deprescribe inappropriate medications (sedative-hypnotics, first-generation antihistamines, selective nonsteroidal anti-inflammatory drugs, glyburide)
Trial: 31765004
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose aspirin (100 mg) for primary prevention
Trial: 28431432
Drug: 24 mg
RxNorm normalized name: uracil 224 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 mg total macular carotenoids
Trial: 25510442
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 μg per day)
Trial: 19624626
Drug: Remifentanil 1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1, 2, 3, 4, or 5 microg.kg(‐1) co-administered with propofol 2.5 mg.kg(‐1)
Trial: 9706948
Drug: Codeine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine (1 mg/kg)
Trial: 7653811
Drug: Acetaminophen (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (15 mg/kg)
Trial: 11767272
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of physostigmine (100 microl, 2-8 mg/ml) for 1 min in healthy subjects
Trial: 8516307
Drug: L‐697,661
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐697,661
Trial: 3802717
Drug: Acute ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute ethanol administration
Trial: 29701039
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at Zhiyang (GV 9) Bazhen points combined with pantoprazole (40 mg once a day)
Trial: 29701039
Drug: Pantoprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (40 mg once a day)
Trial: 8372265
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg intravenous diclofenac
Trial: 31599084
Drug: Vasopressor infusion
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressor infusion via peripheral venous catheters (PVC)
Trial: 31599084
Drug: Vasopressor infusion
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressor infusion via central venous catheters (CVC)
Trial: 21316535
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 influenza vaccine (7.5-μg doses) administered with a 2-week interval between doses
Trial: 21316535
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 influenza vaccine (7.5-μg doses) administered with a 3-week interval between doses
Trial: 21316535
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 influenza vaccine (7.5-μg doses)
Trial: 9509206
Drug: 1000 ml
RxNorm normalized name: TPN Bag 1000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 ml of compound sodium lactate solution during surgery
Trial: 2494454
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (1.5 million units over 30 minutes)
Trial: 2494454
Drug: Intravenous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous recombinant tissue plasminogen activator (rt-PA) (100 mg over three hours)
Trial: 8507540
Drug: PAC plus
RxNorm normalized name: Nutritional Supplement Oral Powder for Suspension [PROPAC PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAC plus SPG combination therapy
Trial: 8507540
Drug: PAC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAC therapy
Trial: 30621742
Drug: Single-shot sciatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-shot sciatic nerve block with 2 mg/ml ropivacaine, 20 ml
Trial: 21422239
Drug: Sodium 2,2
RxNorm normalized name: DISODIUM 2,2'-DIHYDROXY-4,4'-DIMETHOXY-5,5'-DISULFOBENZOPHENONE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium 2,2 dimethylbutyrate (SDMB) at doses of 2, 5, 10, and 20 mg/kg single dose or 5, 10, or 15 mg/kg daily for 14 days
Trial: 17716544
Drug: Tomato-rich diet
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato-rich diet (300 g tomatoes daily for 1 month)
Trial: 31017639
Drug: Integrated Prolonged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Prolonged Exposure (I-PE) therapy
Trial: 31017639
Drug: Integrated Coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Coping Skills (I-CS) therapy
Trial: 26236997
Drug: egg oral
RxNorm normalized name: Egg Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: egg oral immunotherapy (egg‐OIT) for 3 months (maintenance dose one undercooked egg every 48 hours)
Trial: 18074149
Drug: Ceftibuten (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (9 mg/kg once daily for 14 days)
Trial: 18074149
Drug: Ceftriaxone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (50 mg/kg once daily for 3 days) followed by Ceftibuten (for 11 days)
Trial: 12650133
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 microg thrice weekly
Trial: 12650133
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 microg once daily
Trial: 3051550
Drug: Maloprim (pyrimethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maloprim (pyrimethamine and dapsone) administered fortnightly for 2 years
Trial: 25003624
Drug: Soy isoflavones
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isoflavones 80 mg/day
Trial: 23605375
Drug: Control (non-treatment)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (non-treatment)
Trial: 22097197
Drug: Safflower Injection
RxNorm normalized name: SAFFLOWER
DrugBank: Safflower (DB10905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower Injection (20 mL in 250 mL 5% glucose injection, administered intravenously once per day for 1-7 days)
Trial: 22097197
Drug: Dextran-40 (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran-40 (administered intravenously once per day for 1-7 days)
Trial: 22097197
Drug: Safflower Injection
RxNorm normalized name: SAFFLOWER
DrugBank: Safflower (DB10905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower Injection
Trial: 16838647
Drug: Interferon as
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon as maintenance therapy following chemotherapy or autologous stem cell transplantation
Trial: 16838647
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy during induction therapy
Trial: 16838647
Drug: Interferon as
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon as maintenance therapy for patients responding to first-line therapy
Trial: 14738559
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy with 6 MU IFN alpha three times a week
Trial: 7900949
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day zidovudine
Trial: 25268567
Drug: High-dose progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose progesterone (PG)
Trial: 18584369
Drug: Hydroxocobalamin (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxocobalamin (2.5, 5, 7.5, or 10 g) administered intravenously over 7.5 to 30 minutes